Your session is about to expire
← Back to Search
Veteran Social Support for Smoking Cessation (VAntage Trial)
N/A
Recruiting
Led By Steven S. Fu, MD MSCE
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial studies how social support helps Veterans quit smoking. Veterans choose a support person to help them quit or prepare for quitting. This helps us learn how to better help Veterans stop smoking.
Who is the study for?
This trial is for Veterans who smoke cigarettes and have a support person willing to help them quit. The Veteran must be using cigarettes primarily if they use other tobacco products, and should have smoked at least once in the past month. Their chosen support person needs to be an adult they're in contact with at least three times a week.
What is being tested?
The study tests whether having a support person receiving coaching calls and written materials can enhance smoking cessation efforts among Veterans. It aims to determine how social support affects the quitting process, potentially leading to new tailored cessation strategies.
What are the potential side effects?
Since this trial involves behavioral interventions like coaching calls and educational materials rather than medications, there are no direct medical side effects. However, participants may experience stress or emotional discomfort during the quitting process.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Biochemically confirmed 7-day point prevalence cigarette smoking abstinence
Prolonged smoking abstinence
Self-reported 7-day point prevalence cigarette smoking abstinence
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Support Person Coaching Call and Written MaterialsExperimental Treatment3 Interventions
Support persons will receive written material resources on support strategies to stop smoking, and resources on how to stop smoking. Support person participants assigned to the intervention group will additionally receive a 1-call coaching session about 15-25 minutes in duration on how to support their Veteran smoker. The coaching session will be delivered by research staff by phone or video call. Veteran smokers will receive written smoking cessation resource and referral information for VHA and non-VHA EBCT options.
Group II: Written Materials OnlyActive Control2 Interventions
Support persons will receive written material resources on support strategies to stop smoking, and resources on how to stop smoking. Veteran smokers will receive written smoking cessation resource and referral information for VHA and non-VHA EBCT options.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,665 Previous Clinical Trials
3,763,401 Total Patients Enrolled
Steven S. Fu, MD MSCEPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
3 Previous Clinical Trials
9,703 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a working phone number.
Research Study Groups:
This trial has the following groups:- Group 1: Support Person Coaching Call and Written Materials
- Group 2: Written Materials Only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.